ECO Animal Health Group plc (EAH.L) LSE
93.00
-2(-2.11%)
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
93.00
-2(-2.11%)
Currency In GBp
Address
78 Coombe Road
New Malden, KT3 4QS
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 20 8336 2900
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
227
First IPO Date
September 26, 1995
| Name | Title | Pay | Year Born |
| David Charles Hallas | Chief Executive Officer & Director | 431,000 | 1964 |
| Christopher Wilks | Chief Financial Officer, Finance Director, Secretary & Director | 367,000 | 1964 |
| Andrew Winder | Head of Business Development | 0 | N/A |
| Andrew Buglass | Chief Commercial Officer | 0 | N/A |
ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is headquartered in New Malden, the United Kingdom.